Log in
Enquire now
‌

US Patent 12110337 Anti-CD27 antibodies and uses thereof

Patent 12110337 was granted and assigned to Bristol-Myers Squibb Company on October, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
Bristol-Myers Squibb Company
Bristol-Myers Squibb Company
0
Date Filed
April 3, 2019
0
Date of Patent
October 8, 2024
0
Patent Applicant
Bristol-Myers Squibb Company
Bristol-Myers Squibb Company
0
Patent Application Number
17045143
0
Patent Citations
‌
US Patent 9527916 Agonistic antibody to CD27
0
‌
US Patent 7943743 Human monoclonal antibodies to programmed death ligand 1 (PD-L1)
0
‌
US Patent 8008449 Human monoclonal antibodies to programmed death 1 (PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics
0
‌
US Patent 8217149 Anti-PD-L1 antibodies, compositions and articles of manufacture
0
‌
US Patent 9683046 Nucleic acid molecules encoding anti-CD27 antibodies
0
Patent Inventor Names
Guodong Chen
0
Li-Sheng Lu
0
Mohan Srinivasan
0
Haichun Huang
0
Jun Zhang
0
Ekaterina Deyanova
0
Mark J. Selby
0
Shrikant Deshpande
0
Alan J. Korman
0
Richard Y. Huang
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
12110337
0
Patent Primary Examiner
‌
Claire Kaufman
0

Find more entities like US Patent 12110337 Anti-CD27 antibodies and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.